Search for other papers by Muriel Houang in
Google Scholar
PubMed
Search for other papers by Thao Nguyen-Khoa in
Google Scholar
PubMed
Département de Métabolomique Clinique, Hôpital Saint-Antoine, AP-HP Sorbonne Université, Paris, France
Search for other papers by Thibaut Eguether in
Google Scholar
PubMed
Département de Métabolomique Clinique, Hôpital Saint-Antoine, AP-HP Sorbonne Université, Paris, France
Search for other papers by Bettina Ribault in
Google Scholar
PubMed
Search for other papers by Séverine Brabant in
Google Scholar
PubMed
Université de Paris, INSERM, Institut IMAGINE, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
Search for other papers by Michel Polak in
Google Scholar
PubMed
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France
Hôpital Armand Trousseau, AP-HP Sorbonne Université, Paris, France
Search for other papers by Irène Netchine in
Google Scholar
PubMed
Département de Métabolomique Clinique, Hôpital Saint-Antoine, AP-HP Sorbonne Université, Paris, France
Search for other papers by Antonin Lamazière in
Google Scholar
PubMed
, respectively, with positive predictive values (PPVs) of 12.0 and 16.1%, respectively. Different factors could explain such a low PPV: (i) cross-reactive detection of 17-OHP with its steroid precursors and their sulphated conjugates, which are present in the
Search for other papers by Amit Kumar in
Google Scholar
PubMed
Search for other papers by Maria Ghosh in
Google Scholar
PubMed
Search for other papers by Jubbin Jagan Jacob in
Google Scholar
PubMed
levels >10 mg/dL (100 g/L) were excluded. Patients receiving mannitol infusions were excluded. Other exclusion criteria included patients with blood glucose values >400 mg/dL (22.2 mmol/L), those who received oral or i.v. steroids within the last 6 months
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Anne-Marie Till in
Google Scholar
PubMed
Search for other papers by Caroline Stille in
Google Scholar
PubMed
Search for other papers by Tabea Lamprecht in
Google Scholar
PubMed
Search for other papers by Simon Vieth in
Google Scholar
PubMed
Search for other papers by Melchior Lauten in
Google Scholar
PubMed
adrenal gland-related toxicity in ALL ( 3 , 4 , 5 , 6 , 7 , 8 ). However, adrenal insufficiency may affect different steroids differently and each effect may have distinct clinical consequences. Global adrenal insufficiency affects both
Search for other papers by I Savchuk in
Google Scholar
PubMed
Search for other papers by M L Morvan in
Google Scholar
PubMed
Search for other papers by J P Antignac in
Google Scholar
PubMed
Search for other papers by K Gemzell-Danielsson in
Google Scholar
PubMed
Search for other papers by B Le Bizec in
Google Scholar
PubMed
Search for other papers by O Söder in
Google Scholar
PubMed
Search for other papers by K Svechnikov in
Google Scholar
PubMed
Introduction Steroid hormones produced by the human fetal adrenal glands (HFA) have been proposed to regulate intrauterine homeostasis and the maturation of certain organs required for extrauterine life ( 1 ). In this case, appropriate
Search for other papers by Roberto Cosimo Melcangi in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Samantha Sperduti in
Google Scholar
PubMed
Search for other papers by Silvia Giatti in
Google Scholar
PubMed
Search for other papers by Silvia Diviccaro in
Google Scholar
PubMed
Search for other papers by Maria Grimoldi in
Google Scholar
PubMed
Search for other papers by Donatella Caruso in
Google Scholar
PubMed
Search for other papers by Guido Cavaletti in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
of erection was produced ( 18 ). PFS etiopathogenesis remains elusive. Three different clinical studies ( 18 , 25 , 26 ) demonstrated that finasteride treatment not only affects the steroids directly related with the enzyme 5α-R but has broad
Search for other papers by Lesley A Hill in
Google Scholar
PubMed
Search for other papers by Zeynep Sumer-Bayraktar in
Google Scholar
PubMed
Search for other papers by John G Lewis in
Google Scholar
PubMed
Search for other papers by Eva Morava in
Google Scholar
PubMed
Search for other papers by Morten Thaysen-Andersen in
Google Scholar
PubMed
Search for other papers by Geoffrey L Hammond in
Google Scholar
PubMed
Introduction Corticosteroid-binding globulin (CBG) transports steroids in the blood and regulates their access to tissues and cells ( 1 , 2 ). Crystal structure analyses show that CBG contains a single hydrophobic steroid-binding site ( 3
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Eric Seidel in
Google Scholar
PubMed
Search for other papers by Gudrun Walenda in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Clemens Messerschmidt in
Google Scholar
PubMed
Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany
Search for other papers by Benedikt Obermayer in
Google Scholar
PubMed
Search for other papers by Mirko Peitzsch in
Google Scholar
PubMed
Search for other papers by Paal Wallace in
Google Scholar
PubMed
Search for other papers by Rohini Bahethi in
Google Scholar
PubMed
Search for other papers by Taekyeong Yoo in
Google Scholar
PubMed
Search for other papers by Murim Choi in
Google Scholar
PubMed
Search for other papers by Petra Schrade in
Google Scholar
PubMed
Search for other papers by Sebastian Bachmann in
Google Scholar
PubMed
Search for other papers by Gerhard Liebisch in
Google Scholar
PubMed
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
Search for other papers by Dieter Beule in
Google Scholar
PubMed
Berlin Institute of Health (BIH), Berlin, Germany
Department of Nephrology, School of Medicine, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
Search for other papers by Ute I Scholl in
Google Scholar
PubMed
normalized to total protein quantity in mg, as previously described ( 17 ). Measurement of supernatant steroid hormones Cells were seeded on a 12-well plate. After 48 h, medium was replaced. After 24 h, cell supernatants were removed and quickly
Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Paal Methlie in
Google Scholar
PubMed
Search for other papers by Steinar Hustad in
Google Scholar
PubMed
Search for other papers by Ralf Kellman in
Google Scholar
PubMed
Search for other papers by Bjørg Almås in
Google Scholar
PubMed
Search for other papers by Martina M Erichsen in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, University of Bergen, N-5021 Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
's syndrome (CS) and congenital adrenal hyperplasia, male hypogonadism and female hyperandrogenism. Although immunoassays have largely been used to measure steroid hormones, over the last decade, mass spectrometry (MS) has increasingly been adopted as it
Search for other papers by Silvia Ciancia in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
are reversible, with sex steroid production and pubertal development resuming once the medication is discontinued. Several strategies are available to suppress pubertal development and/or the effects of endogenous sex steroids in the context of TGD
Search for other papers by Enrique Pedernera in
Google Scholar
PubMed
Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed
Search for other papers by María J Gómora in
Google Scholar
PubMed
Search for other papers by Miguel A Almaraz in
Google Scholar
PubMed
Universidad La Salle, Posgrado de la Facultad de Ciencias Químicas, Ciudad de México, México
Search for other papers by Esteban Mena in
Google Scholar
PubMed
Search for other papers by Delia Pérez-Montiel in
Google Scholar
PubMed
Search for other papers by Elizabeth Rendon in
Google Scholar
PubMed
Search for other papers by Horacio López-Basave in
Google Scholar
PubMed
Search for other papers by Juan Maldonado-Cubas in
Google Scholar
PubMed
Search for other papers by Carmen Méndez in
Google Scholar
PubMed
female reproductive events. Further, ovarian tumors are considered sensitive to sex steroid hormones, as they are mediated by specific androgen, estrogen, and progesterone receptors ( 3 ). Additionally, the steroid hormone receptor shows a particular